Bluebird bio was hit with a patent infringement lawsuit last week from a Chicago-based biotech it has had an ongoing beef with calling for $2 billion to help cure the “irreparable harm” caused by alleged willful infringement.nBluebird bio is facing a lawsuit from Errant Gene Therapeutics for violating patent law in two instances, the company says.